Schwarz Pharma Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Schwarz Pharma Inc.
Private Company Edition: Clover’s $230m financing was the largest of recent mega-rounds. Century Therapeutics ($160m), Vividion ($135m) and eGenesis ($125m) also raised big rounds and investors Foresite Capital ($969m), Sofinnova Partners ($540m) and OMX Ventures ($150m) raised new VC funds.
Sobi is extending its reach in international markets including Russia and China and expects its late-stage R&D pipeline to drive growth.
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.
Pfizer and BioNTech's COVID-19 vaccine picks up its third emergency authorization, with all eyes now on the final decision from the US FDA. Elsewhere, there are changes at the UK's vaccine taskforce, while Korea is moving ahead with vaccine development plans.